Characterization of the biosynthesis, processing and kinetic mechanism of action of the enzyme deficient in mucopolysaccharidosis IIIC
- PMID: 21957468
- PMCID: PMC3177862
- DOI: 10.1371/journal.pone.0024951
Characterization of the biosynthesis, processing and kinetic mechanism of action of the enzyme deficient in mucopolysaccharidosis IIIC
Abstract
Heparin acetyl-CoA:alpha-glucosaminide N-acetyltransferase (N-acetyltransferase, EC 2.3.1.78) is an integral lysosomal membrane protein containing 11 transmembrane domains, encoded by the HGSNAT gene. Deficiencies of N-acetyltransferase lead to mucopolysaccharidosis IIIC. We demonstrate that contrary to a previous report, the N-acetyltransferase signal peptide is co-translationally cleaved and that this event is required for its intracellular transport to the lysosome. While we confirm that the N-acetyltransferase precursor polypeptide is processed in the lysosome into a small amino-terminal alpha- and a larger ß- chain, we further characterize this event by identifying the mature amino-terminus of each chain. We also demonstrate this processing step(s) is not, as previously reported, needed to produce a functional transferase, i.e., the precursor is active. We next optimize the biochemical assay procedure so that it remains linear as N-acetyltransferase is purified or protein-extracts containing N-acetyltransferase are diluted, by the inclusion of negatively charged lipids. We then use this assay to demonstrate that the purified single N-acetyltransferase protein is both necessary and sufficient to express transferase activity, and that N-acetyltransferase functions as a monomer. Finally, the kinetic mechanism of action of purified N-acetyltransferase was evaluated and found to be a random sequential mechanism involving the formation of a ternary complex with its two substrates; i.e., N-acetyltransferase does not operate through a ping-pong mechanism as previously reported. We confirm this conclusion by demonstrating experimentally that no acetylated enzyme intermediate is formed during the reaction.
Conflict of interest statement
Figures
Similar articles
-
Analysis of the biogenesis of heparan sulfate acetyl-CoA:alpha-glucosaminide N-acetyltransferase provides insights into the mechanism underlying its complete deficiency in mucopolysaccharidosis IIIC.J Biol Chem. 2010 Oct 8;285(41):31233-42. doi: 10.1074/jbc.M110.141150. Epub 2010 Jul 22. J Biol Chem. 2010. PMID: 20650889 Free PMC article.
-
An acetylated 120-kDa lysosomal transmembrane protein is absent from mucopolysaccharidosis IIIC fibroblasts: a candidate molecule for MPS IIIC.Mol Genet Metab. 2006 Jan;87(1):22-31. doi: 10.1016/j.ymgme.2005.09.021. Epub 2005 Nov 15. Mol Genet Metab. 2006. PMID: 16293432
-
Genetic evidence for transmembrane acetylation by lysosomes.Science. 1986 Sep 5;233(4768):1087-9. doi: 10.1126/science.3090688. Science. 1986. PMID: 3090688
-
Sanfilippo syndrome type C: mutation spectrum in the heparan sulfate acetyl-CoA: alpha-glucosaminide N-acetyltransferase (HGSNAT) gene.Hum Mutat. 2009 Jun;30(6):918-25. doi: 10.1002/humu.20986. Hum Mutat. 2009. PMID: 19479962 Review.
-
The mechanism of N-terminal acetylation of proteins.CRC Crit Rev Biochem. 1985;18(4):281-325. doi: 10.3109/10409238509086784. CRC Crit Rev Biochem. 1985. PMID: 3902358 Review.
Cited by
-
Structure of the human heparan-α-glucosaminide N-acetyltransferase (HGSNAT).bioRxiv [Preprint]. 2024 Jun 12:2023.10.23.563672. doi: 10.1101/2023.10.23.563672. bioRxiv. 2024. Update in: Elife. 2024 Aug 28;13:RP93510. doi: 10.7554/eLife.93510 PMID: 37961489 Free PMC article. Updated. Preprint.
-
Evaluation of N-nonyl-deoxygalactonojirimycin as a pharmacological chaperone for human GM1 gangliosidosis leads to identification of a feline model suitable for testing enzyme enhancement therapy.Mol Genet Metab. 2012 Sep;107(1-2):203-12. doi: 10.1016/j.ymgme.2012.06.007. Epub 2012 Jun 19. Mol Genet Metab. 2012. PMID: 22784478 Free PMC article.
-
Neuronal and Astrocytic Differentiation from Sanfilippo C Syndrome iPSCs for Disease Modeling and Drug Development.J Clin Med. 2020 Feb 28;9(3):644. doi: 10.3390/jcm9030644. J Clin Med. 2020. PMID: 32121121 Free PMC article.
-
Pathogenic Roles of Heparan Sulfate and Its Use as a Biomarker in Mucopolysaccharidoses.Int J Mol Sci. 2022 Oct 3;23(19):11724. doi: 10.3390/ijms231911724. Int J Mol Sci. 2022. PMID: 36233030 Free PMC article. Review.
-
Sanfilippo Syndrome: Molecular Basis, Disease Models and Therapeutic Approaches.Int J Mol Sci. 2020 Oct 22;21(21):7819. doi: 10.3390/ijms21217819. Int J Mol Sci. 2020. PMID: 33105639 Free PMC article. Review.
References
-
- Kresse H, Von Figura K, Klein U. A new biochemical subtype of the Sanfilippo syndrome: characterization of the storage material in cultured fibroblasts of Sanfilippo C patients. Euro J Biochem. 1978;92:333–339. - PubMed
-
- Neufeld EF, Muenzer J. The Mucopolysaccharides. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The Metabolic and Molecular Bases of Inherited Disease. 8 ed. New York: McGraw-Hill; 2001. pp. 3421–3452.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
